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INTRODUCTION
Non-typhoidal Salmonella are important
foodborne pathogens that cause gastroenteritis,
bacteremia, and subsequent focal infection. These
hardy bacteria are especially problematic in a wide
variety of immunocompromised individuals, in-
cluding (but not limited to) patients with malig-
nancy, human immunodeficiency virus (HIV) in-
fection, or diabetes, and those receiving corticos-
teroid therapy or treatment with other immuno-
suppressive agents (Hohmann, 2001).
The progressive cellular immune defects
associated with human immunodeficiency virus
infections have led to an increased frequency of
opportunistic infections with intracellular bacte-
rial pathogens, such as non-typhoidal Salmonella
species (Levine et al, 1991). Salmonella bacter-
emia is one manifestation of immunosuppression
in patients with human immunodeficiency virus
infection, and the development of bacteremia rep-
resents a frequent and severe complication in
AIDS patients. Persons with HIV infections have
an estimated 20- to 100- fold increased risk of
salmonellosis compared with the general popu-
lation (Celum et al, 1987; Tocalli et al, 1991).
Salmonella is more likely to cause severe inva-
sive disease in persons with acquired immuno-
deficiency syndrome (AIDS) than in immuno-
competent persons, including fulminant diarrhea,
acute enterocolitis, rectal ulceration, recurrent
bacteremia, meningitis, and death, despite anti-
microbial therapy (Tocali et al, 1991; Angulo and
Swerdlow, 1995).
Recurrent episodes are characteristic of non-
typhoidal Salmonella septicemia in the AIDS
population and are mainly associated with Sal-
monella enterica serotype Enteritidis or Salmo-
nella enterica serotype Typhimurium. Indeed,
since 1987, recurrent non-typhoidal Salmonella
bacteremia has been included in the diagnostic
criteria for AIDS. Recurrent infection apparently
results from incomplete clearance of the primary
infection because of impaired cell-mediated im-
munity, and without maintenance antimicrobial
therapy, up to 45% of persons with HIV infection
will have recurrent bacteremia (Sperber and
Schleupner, 1987). However, in the developed
countries, the incidence of recurrent non-ty-
phoidal Salmonella bacteremia in persons with
HIV has declined in recent years (Angulo and
Swerdlow, 1995). This decline may be linked to
the introduction of zidovudine in 1987 and to the
use of trimethoprim-sulphamethoxazole for the
prevention of Pneumocystis pneumonia (Salmon
et al, 1991). Zidovudine is active against Salmo-
nella in vitro at therapeutic serum concentrations
and against Salmonella-infected macrophages
(Keith et al, 1989; Hermann et al, 1990).
In Malaysia, the first HIV case was reported
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in December 1986 at the University of Malaya
Medical Center. Since then, the number of HIV
infections reported has continued to rise. As of
31 December 2000, a total of 38,340 HIV-posi-
tive cases (0.16% of the total population) were
notified to the Ministry of Health, with a mortal-
ity of 9.30%. Five thousand, one hundred and
seven new HIV infections and 1,168 new AIDS
cases were reported in the year 2000. Males com-
prised 94.7%, and 81.5% were with an age range
20-39 years. The majority of the HIV-infected
persons (76.1%) were intravenous drug users and
71.2% of them had shared needles (Juita and
Osman, 1995; Department of Statistics Malay-
sia, 2001). The racial composition was 72.3%
Malays, 15.4% Chinese, 8.8% Indians, others
0.9%, and 2.5% foreigners. Transmission by het-
erosexual route accounted for 10.8% of the HIV
carriers, and the percentage has been on an up-
ward trend in recent years. A retrospective analy-
sis of a cohort of HIV-infected persons seen at
UHKL from 1986-1996 showed that the propor-
tion of heterosexually-acquired HIV infections
had rapidly increased from 20% in 1994 to 38.9%
in 1996. An increasing number of women were
infected through sexual contact with their hus-
bands (Ismail, 1998).
Human salmonellosis is initiated by the in-
gestion of food or water contaminated with one
or other Salmonella strain. Non-typhoidal Salmo-
nella infection is widely distributed among dif-
ferent animal species but is particularly preva-
lent in animals raised for food. Salmonella or-
ganisms may be cultured from approximately
50% of commercially available chickens, from
20% of frozen egg whites, from varying percent-
ages of raw milk sources, and periodically, from
ground beef used to make hamburgers (Wilder
and MacCeady, 1966; Goldberg and Rubin, 1988).
This report is a retrospective review of seven
cases of Salmonella bacteremia in HIV-infected
or AIDS patients seen at the University Hospital,
Kuala Lumpur, Malaysia over a period of 12
years. To the best of our knowledge there are no
reports of such cases from Malaysia.
PATIENTS AND METHODS
All patients with positive blood cultures for
Salmonella species and serologically positive for
HIV infection, from 1991 to 2003, were included
in the study. Patients’ records were reviewed for
demographic data, ie age, sex, ethnic group, oc-
cupation, sexual preference, history of intrave-
nous drug usage, dietary habits, and for the pre-
sence of other risk and comorbid factors.
The Salmonella isolates were identified by
standard biochemical reactions. Salmonella
enterica Typhi isolates were differentiated from
other Salmonella species by their inability to pro-
duce gas on fermentation of carbohydrates.
Serotyping of the strains was performed at the
Institute for Medical Research, Kuala Lumpur,
the National Reference Laboratory for Salmo-
nella. Antibiotic susceptibility testing was carried
out using standard disc diffusion procedures.
Screening for HIV antibodies was carried out
using Abbott AxySm microparticle enzyme im-
munoassay (MEIA) HIV 1/2 (Abbott Laborato-
ries Diagnostics Division, Abbott Park, USA). All
samples negative for anti-HIV 1/2 antibodies were
considered negative. A particle agglutination (PA)
assay (Serodia HIV-1/2, Fujirebio Inc, Japan) was
used as a supplementary test to confirm samples
that were repeatedly MEIA anti-HIV 1/2 antibody
reactive. Inno-Lia HIV (Innogenetics NV, Bel-
gium) carried out according to the manufacturer’s
recommendations, was used as a confirmatory
assay. Only samples repeatedly reactive with
MEIA, PA positive and with specific bands
present on the nylon strip of Inno-LIa HIV, were
considered positive for HIV infection.
Case histories
Table 1 summarizes the relevant data of the
seven HIV/AIDS cases with Salmonella bacter-
emia. All were adult patients between the ages of
30 and 61 years and all, except one, were males.
Five patients were Chinese, one was Malay, and
one Indian, the only female, was admitted for a
lung infection and a recent history of diarrhea and
vomiting. Her blood culture grew Streptococcus
pneumoniae and Salmonella enterica Enteritidis
and then only was she diagnosed as HIV-posi-
tive. She gave a history of blood transfusion one
and a half years ago. Of the remaining six males,
three were intravenous drug users and one ad-
mitted to smoking marijuana. None of them were
involved in homosexual activity. Promiscuity was
admitted by two. Salmonella was isolated from
the blood cultures of all of them and two had re-
current cultures positive over a period of time.
All except one were treated with ceftriaxone in
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tures, one stool and one urine specimen posi-
tive over a period of one year, until December
1991. He was not homosexual and was briefly
married and traveled extensively in Europe. He
was an artist and painter by profession and
admitted to intravenous drug abuse and pro-
miscuity.
Case 7. A 40-year-old Chinese businessman was
admitted in January 2002 with persistent pussy
discharge from the right loin, progressive lower
limb swelling, abdominal distension for two
weeks, and loss of appetite. A past history of
being treated for pulmonary tuberculosis and
abscess on his pelvis was elicited. He was di-
Table 1
Salmonella septicemia in HIV-infected patients.
Case Age (yr)/ Risk / Comorbid Source of Salmonella Antimicrobial Duration of
No. Sex factors organism  serovar  therapy HIV infection
1 34 IVDU Blood x 5 Typhimurium Chloramphenicol 4 years
M Heterosexual Stool x 1 Ampicillin
Promiscuity Urine x 4 Co-T
Pneumocystis carinii Ceftriaxone
Oral thrush Ciprofloxacin
Ketoconazole
2 61 Blood transfusion Blood x 1 Enteritidis C. Penicillin Post-
F Lobar pneumonia Ceftriaxone Salmonella
septicemia
3 52 IVDU Blood x 1 Group  D Ampicillin- 3 years
M Mycotic aneurysm Tissue from sulbactam
aneurysm
4 34 IVDU
M Heterosexual Blood x 1 Enteritidis Ceftriaxone 2 weeks
Oral thrush Co-T
Bronchopneumonia Itraconazole
5 41 Heterosexual Blood x 1 Enteritidis Co-T 2 months
M Promiscuity Ceftriaxone
Pulmonary TB - 2 years Itraconazole
Oral thrush
6 30 Marijuana smoker Blood x 1 Enteritidis Co-T Known
M Heterosexual Ceftriaxone history-?yrs
Cerebral toxoplasmosis Metronidazole
Itraconazole
7 40 Heterosexual Blood x 1 Typhimurium Ceftriaxone 13 years
M No history of drug Stool x 1 Ciprofloxacin
abuse, pulmonary TB Pus x 5 Co-T
Diarrhea, pleural effusion
IVUD - intravenous drug user; Co-T - trimethoprim-sulphamethoxazole
combination with other drugs, such as co-
trimoxazole, ciprofloxacin, or an antifungal agent.
The following is a more detailed report of cases
number one and seven; both had recurrent sal-
monellosis.
Case 1. A 34-year-old Chinese man was admit-
ted in November 1990 with a history of fever
for one month associated with chills and rig-
ors. He had been diagnosed HIV-positive in
1987, and had a previous history of admission
for fever and oral thrush. Blood culture grew
Salmonella enterica Typhimurium and he was
given chloramphenicol. He had recurrent epi-
sodes of salmonellosis and had five blood cul-
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agnosed HIV-positive in 1990, but denied ho-
mosexuality or drug abuse. On clinical exami-
nation, he was found to be cachexic with mod-
erate dehydration. Edema of both legs, abscesses
on the posterior abdominal wall and in the right
loin, pleural effusion, right lung consolidation,
cardiomegaly, abscesses in the liver, ascites and
shotty nodes in the para-aortic areas were
present. He also suffered from persistent wa-
tery diarrhea. Over a period of several months,
S. enterica Typhimurium was isolated from
several pus aspirates including lymph nodes,
psoas abscess, as well as from blood culture
and peritoneal fluid. He was treated with
ceftriaxone and ciprofloxacin.
DISCUSSION
Human immunodeficiency virus infection
produces complex and progressive immunologi-
cal deterioration that leads to a marked suscepti-
bility to infections caused not only by typically
opportunistic pathogens but also by microorgan-
isms that cause common infections in the general
population (Brettle, 1997), and the invasion of
the blood stream is a critical clinical circumstance
in any bacterial infection.
The most commonly recognized clinical syn-
drome caused by non-typhoidal Salmonella is gas-
troenteritis. But in AIDS patients, due to defec-
tive macrophage killing of these intracellular or-
ganisms, bacteremia occurs in as many as 70%
of them. In contrast, bacteremic complications of
Salmonella gastroenteritis occur only in 1%-4%
of patients without underlying disease. Surpris-
ingly, results of stool cultures are often negative,
even when diarrhea is present (Celum et al, 1987),
as only two patients in our series had positive stool
cultures.
Salmonella enterica Typhimurium and Sal-
monella enterica Enteritidis have been the two
most common serovars associated with infections
in HIV/AIDS patients (Levine et al, 1991) and
this is reflected in our small series. But these two
serovars are also most commonly isolated from
gastroenteritis as well as nontyphoidal Salmonella
bacteremic cases in Malaysia, (Lee et al, 2000;
2003). Unfortunately, the organism from case
number three was not available for speciation but
was identified as group D and highly likely to
have been S. enterica Enteritidis.
The virulence of any microorganism in-
volves a complex interaction between the micro-
organism and the host’s ability to limit infection.
In Salmonella infection, host specificity is ex-
tremely important to disease and an intact cell-
mediated immunity is vital in controlling this in-
tracellular pathogen. Persons deficient in the
interleukin-12 receptor are extremely susceptible
to Salmonella infections, because interleukin-12
induces type 1 helper T-cell responses and inter-
feron-γ  production, and this innate immune path-
way is necessary in resistance to salmonellosis
(Angulo and Swerdlow, 1995; de Jong et al,
1998).
None of the seven patients was known to be
homosexual and this is consistent with studies
suggesting that Salmonellae do not occur com-
monly among gay men as pathogens or as colo-
nizing organisms. On the other hand, a relatively
high proportion of heterosexual intravenous drug
users with HIV/AIDS infection had recurrent
nontyphoidal Salmonella septicemia (Levine et
al, 1991). In the present series of seven cases,
three were intravenous drug users.
 A study by Gordon et al (2002) found that
non-typhoidal Salmonella bacteremia had a high
recurrence rate (43%) in HIV-infected African
adults and suggested that recurrence is caused by
recrudescence rather than re-infection. As focal
infections were rarely found, recrudescence may
often have been a consequence of intracellular
tissue sequestration.
In humans, non-typhoidal Salmonella infec-
tions are most often associated with food pro-
ducts. Foods of animal origin, including meat,
poultry, eggs, or dairy products, can become con-
taminated with Salmonella. Eating uncooked or
inadequately cooked food, or food cross-contami-
nated with these products, may lead to infection.
Salmonellosis can also be associated with domes-
tic and exotic pets, such as snakes, iguanas, turtles,
birds, rodents, dogs and cats (Glaser et al, 1994).
We were unable to ascertain the sources of the
organism in our patients.
In HIV/AIDS-infected persons, the first epi-
sode of Salmonella bacteremia should be treated
with one to two weeks of intravenous antimicro-
bial therapy followed by four weeks of oral
quinolone therapy in an attempt to eradicate the
organism and decrease the risk of recurrent bac-
teremia (Jacobson et al, 1989). Persons who re-
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lapse after six weeks of antimicrobial therapy
should receive long-term suppressive therapy with
a quinolone or trimethoprim-sulphamethoxazole.
Although data are lacking, because of its efficacy
in the prevention of Pneumocystis carinii infec-
tion, trimethoprim-sulphamethoxazole may be a
good choice for long-term suppressive therapy for
salmonellosis if the organism is susceptible (Cen-
ters for Disease Control and Prevention, 1992).
Two of our patients had recurrent episodes of
Salmonella infection in spite of being on suppres-
sive therapy and we suspect non-compliance was
the cause.
The control and prevention of salmonello-
sis requires coordinated efforts on multiple lev-
els, including the farm, food processors, and food
handlers. Effort must be made to educate HIV-
infected persons on the epidemiology of salmo-
nellosis and food counseling for such persons,
aimed at prevention of infection, should be un-
dertaken. Such patients may benefit from educa-
tion in safe food handling and preparation prac-
tices (Levine et al, 1991).
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